OncoMutational ratio on ctDNA: A potential novel biomarker in NSCLC

被引：0
|
作者：
Ambrosini, P. [1 ]
Provenzano, L. [1 ]
Bottiglieri, A. [1 ]
Spagnoletti, A. [1 ]
Di Guida, G. [2 ]
Mazzeo, L. [1 ]
Beninato, T. [1 ]
Leporati, R. [3 ]
Occhipinti, M. [4 ]
Brambilla, M. [1 ]
Manglaviti, S. [1 ]
Ganzinelli, M. [4 ]
Miskovic, V. [5 ]
Proto, C. [1 ]
Dumitrascu, A. D. [1 ]
De Braud, F. G. M. [6 ]
Della Corte, C. M. [7 ]
Lo Russo, G. [8 ]
Viscardi, G. [9 ]
Prelaj, A. [10 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
[2] Univ Campania Luigi Vanvitelli, Med Oncol Dept, Caserta, Italy
[3] Ist Nazl Tumori Milano Fdn IRCCS, Oncol Dept, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[5] Politecn Milan, Dipartimento Elettron Informaz & Bioingegneria, Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Med Oncol & Haematol Dept, Milan, Italy
[7] Univ Campania Luigi Vanvitelli, Dipartimento Oncol, Naples, Italy
[8] Fdn IRCCS Ist Nazl Tumori, Dipartimento Oncol Toraco Polmonare, Milan, Italy
[9] Univ Campania Luigi Vanvitelli, Dipartimento Oncol Medica, Naples, Italy
[10] Fdn IRCCS Ist Nazl Tumori, Oncol Medica Torac Dept, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [41] Sclerostin as a Potential Novel Biomarker for Aortic Valve
    Koos, Ralf
    Brandenburg, Vincent
    Mahnken, Andreas Horst
    Schneider, Rebekka
    Dohmen, Guido
    Autschbach, Ruediger
    Marx, Nikolaus
    Kramann, Rafael
    JOURNAL OF HEART VALVE DISEASE, 2013, 22 (03): : 317 - 325
  • [42] MAP4K4 as a therapeutic target and novel biomarker for NSCLC
    Repellin, Claire E.
    Liu, Xiaohe
    Stofega, Mary R.
    Snider, Janey C. L.
    Ao, Zheng
    Jong, Ling
    Sambucetti, Lidia C.
    CANCER RESEARCH, 2016, 76
  • [43] Uric Acid to Albumin Ratio, A Novel Biomarker of Cardiovascular Disease
    Wang, Chun-Song
    Sun, Ying
    Ren, Jian
    ANGIOLOGY, 2024, 75 (04) : 394 - 394
  • [44] TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
    Lou, Ming
    Gao, Zhaojia
    Zhu, Tao
    Mao, Xiaoliang
    Wang, Yeming
    Yuan, Kai
    Tong, Jichun
    ONCOLOGY LETTERS, 2020, 19 (02) : 1400 - 1408
  • [45] Identification and validation of galectin-7 as a novel blood biomarker for NSCLC diagnosis
    Hassanein, Mohamed
    Alborn, William E.
    Carnahan, Robert H.
    Liebler, Daniel C.
    Carbone, David P.
    Massion, Pierre P.
    CANCER RESEARCH, 2011, 71
  • [46] Concordance of ctDNA and tissue mutations in NSCLC: A meta-analysis
    Yu, Chengyuan
    Han, Yitong
    Wang, Mu
    Hua, Peiyan
    Zhang, Yan
    Wang, Bin
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (08) : 89 - 95
  • [47] The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines
    Perez, A.
    Di Stefano, A. B.
    Castiglia, M.
    Sorrentino, M.
    Matranga, D.
    Grisafi, F.
    Corso, C.
    Scoarughi, G.
    Barbato, G.
    Barraco, N.
    Calo, V.
    Di Piazza, F.
    Massihnia, D.
    Listi, A.
    Castellana, L.
    Guarini, A. A.
    Insalaco, L.
    Bronte, E.
    Russo, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] ctDNA detection of EGFR mutations in NSCLC patients using TargetSelector
    Beerkens, Frans
    Kim, Chul
    Hasan, Syed P.
    Subramaniam, Deepa Suresh
    Liu, Stephen V.
    Arnold, Lyle
    Vibat, Cecile Rose T.
    Singh, Veena M.
    Giaccone, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors
    Abbosh, Christopher
    Swanton, Charles
    PLOS MEDICINE, 2021, 18 (10)
  • [50] Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease
    Liu, Jingfeng
    Li, Xing
    Qu, Ji
    NEUROREPORT, 2023, 34 (15) : 767 - 772
12345